Annual Meeting of The Endocrine Society (ENDO 2020)

Diabesity and COVID-19: A critical combination

Roshini Claire Anthony, 20200718120001

The concurrent occurrence of diabesity and COVID-19 may lead to more severe disease due to the latter, according to a presentation at the Opening Session of ENDO Online.

Bariatric surgery may reduce NAFLD risk

Roshini Claire Anthony, 20200611140002

By reducing hepatic enzyme levels and improving markers of hepatic steatosis or fibrosis, bariatric surgery may help reduce the risk of non-alcoholic fatty liver disease (NAFLD), according to a study from Portugal presented at ENDO 2020.

Diabetes affects weight loss magnitude after bariatric surgery

Roshini Claire Anthony, 20200604140002

The magnitude of weight loss following bariatric surgery for obesity may be reduced among individuals who have diabetes prior to surgery, according to a retrospective study presented at ENDO 2020.

Psychiatric comorbidities frequent among transgender teens

Roshini Claire Anthony, 20200603140001

There is a high incidence of psychiatric comorbidities among gender nonconforming teenagers, with about two-thirds and one-third experiencing depression and anxiety, respectively, according to a study presented at ENDO 2020.

Long working hours may up hypothyroidism risk

Roshini Claire Anthony, 20200528150001

A study from South Korea, presented at ENDO 2020, suggested that individuals who work long hours may be at risk of developing hypothyroidism.

Adjunct liraglutide therapy helps lower BMI in obese teens

Elaine Soliven, 20200421000000

Adding liraglutide to first-line lifestyle therapy led to a significantly reduced BMI standard-deviation score (BMI SDS*) among obese adolescents who failed to respond to lifestyle therapy alone, according to a study presented at ENDO 2020.

Oral octreotide: OPTIMAL noinjectable solution for acromegaly?

Audrey Abella, 20200414100000

The investigational, oral formulation of octreotide appeared to be effective and safe as maintenance treatment for adults with acromegaly, according to the results of the phase III OPTIMAL* study presented at ENDO 2020.

Thyroid hormone use may up death risk in older people

Pearl Toh, 20200413190000

Use of thyroid replacement therapy in older people with isolated elevations in TSH* was associated with a significantly increased risk of death than those who were left untreated, according to the BLSA** study presented at ENDO 2020 — which raises the possibility of overtreatment in these older adults.

Teprotumumab casts hope for thyroid eye disease

Audrey Abella, 20200409100000

The human monoclonal anti-IGF-1R* antibody teprotumumab was effective in reducing proptosis or eye bulging in patients with the rare thyroid eye disease (TED) regardless of age, gender, and/or smoking status, according to pooled data presented at ENDO 2020.

Better glycaemic control may help preserve cognitive function after stroke

Pearl Toh, 20200408190000

Maintaining a good control of blood glucose level may slow down the decline of cognitive function in patients with type 2 diabetes (T2D) after a lacunar stroke, suggests a post hoc analysis of the SPS3* trial presented at the ENDO 2020 Virtual Meeting.